| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Sales | 13,913,538 | - |
| Cost of products | 13,015,293 | - |
| Product margin | 898,245 | - |
| Wages and benefits | 123,471 | - |
| Occupancy costs | 97,450 | - |
| Transactional Operating Cost | 67,462 | - |
| Transactional operating costs | 67,462 | - |
| Maintenance | 77,533 | - |
| Other segment operating expenses | 28,967 | - |
| Total operating expenses allocated to operating segments | 394,883 | - |
| Depreciation allocated to cost of sales | 99,274 | - |
| Selling, general and administrative expenses | 224,781 | - |
| Amortization expense | 4,063 | - |
| Net gain on sale and disposition of assets | 2,355 | - |
| Long-lived asset impairment | 231 | - |
| Total operating expenses not allocated to operating expenses | 325,994 | - |
| Operating income | 177,368 | - |
| Income (loss) from equity method investments | 3,071 | - |
| Interest expense | -103,878 | - |
| Loss on early extinguishment of debt | -2,971 | - |
| Income tax benefit (expense) | 671 | - |
| Net income | 72,919 | 43,894 |
| Depreciation and amortization | 107,265 | 72,029 |
| Amortization of deferred financing fees | 5,593 | 3,658 |
| Bad debt expense | 1,091 | 794 |
| Unit-based compensation expense | 10,139 | 6,779 |
| Net gain on sale and disposition of assets | 2,355 | 2,219 |
| Long-lived asset impairment | 231 | 211 |
| (income) loss from equity method investments | 3,071 | 2,416 |
| Dividends received on equity method investments | 477 | - |
| Loss on early extinguishment of debt | -2,971 | -2,795 |
| Accounts receivable | 49,982 | 92,167 |
| Accounts receivable-affiliate | -1,199 | 882 |
| Inventories | -115,018 | -98,148 |
| Broker margin deposits | 464 | 3,744 |
| Prepaid expenses, all other current assets and other assets | -3,649 | 3,167 |
| Accounts payable | -23,632 | 80,377 |
| Trustee taxes payable | -3,266 | 16,663 |
| Change in derivatives | -12,928 | -3,354 |
| Accrued expenses, all other current liabilities and other long-term liabilities | -66,954 | -59,377 |
| Net cash provided by (used in) operating activities | 183,756 | 164,730 |
| Equity method investments | 24,916 | 20,271 |
| Capital expenditures | 52,657 | 32,953 |
| Seller note issuances, net | -531 | -142 |
| Dividends received of equity method investments | 7,746 | 4,676 |
| Proceeds from sale of property and equipment, net | 4,493 | 3,971 |
| Net cash used in investing activities | -64,803 | -44,435 |
| Net borrowings (payments on) from revolving credit facility-Working Capital Facility | 11,100 | -31,000 |
| Net borrowings (payments on) from revolving credit facility-Non Working Capital Facility | -42,200 | -78,800 |
| Proceeds from senior notes, net | 441,208 | 441,377 |
| Repayment of senior notes | 400,000 | 360,316 |
| Repurchase of common units | 7,371 | 3,557 |
| Ltip units withheld for tax obligations | 13,439 | 13,439 |
| Distribution equivalent rights | 4,017 | 4,017 |
| Distributions to limited partners and general partner | 94,510 | 62,654 |
| Net cash (used in) provided by financing activities | -109,229 | -112,406 |
| Increase in cash and cash equivalents | 9,724 | 7,889 |
| Cash and cash equivalents at beginning of period | 8,208 | - |
| Cash and cash equivalents at end of period | 17,932 | - |
GLOBAL PARTNERS LP (GLP)
GLOBAL PARTNERS LP (GLP)